Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-03-18

Clinical Trial Update: Efficacy and Safety of the Association of Clotrimazole and Metronidazole in the Treatment of Vaginal Discharge From Different Etiologies. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a clotrimazole and metronidazole combination for vaginal discharge in sexually active women was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clotrimazole (clotrimazole)
  • METRONIDAZOLE (Metronidazole)

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Sexual Active Women, Vaginal Discharge | Phase 3 | Status: WITHDRAWN